Ramdev's Patanjali launches Coronil kit for ₹545
Patanjali on Tuesday launched 'Coronil and Swasari', what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 per cent favourable results during clinical trials on affected patients, at Patanjali Yogpeeth in Haridwar. Acharya Balkrishna, MD of Patanjali Ayurved, claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 3-14 days.
Baba Ramdev also claims that there are no side-effects of the corona medicines he is launching.
A total of 100 coronavirus positive patients were recruited for the controlled clinical trial, Patanjali claims. Of which 95 were studied, 1 patient was lost on the follow up details and 4 patients withdrew consent between the study, claims Patanjali.
Exclusion criteria for Patanjali clinical study plan (Claimed)
1) Severely symptomatic patients (SaO2 <90%)
2) Acute respiratory distress syndrome
3) Life expectancy less than 1 year due to other co-morbid conditions
Inclusion criteria for Patanjali clinical study plan (Claimed)